Clinical trials & evidence

Resistant hypertension may need a diagnostic revolution, not just another drug

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

The Biomarker Test Cannot Wait Until Relapse

When the Test Says Normal but the Pain Does Not

COVID Vaccines Still Kept Adults Out of Hospital. The Evidence Should Matter.

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
